[1]
Uddin, M.D. et al. 2018. Evaluation of treatment of HER2 positive Breast cancer patients with Trastuzumab combined with cytotoxic chemotherapy – a comparative study. TAJ: Journal of Teachers Association. 26, (Nov. 2018), 30–37. DOI:https://doi.org/10.3329/taj.v26i0.37583.